The main genetic lesions associated with DLBCL-type RS are represented by somatic mutations or disruptions of the TP53, CDKN2A, NOTCH1 and c-MYC genes (Figure 1) [2,5,6,7,33,34]. Here, CDKN2A is linked to diffuse large B-cell lymphoma.